Abstraction Health

Urolithin A

Postbiotic
🟡Moderate Evidence 26 expert mentions 20 studies
D·48/100·Limited
Research Depth25/25
Study Quality13/25
Expert Consensus10/25
Claim Support0/25

A gut-derived compound from polyphenols found in pomegranates and berries. Studied for mitophagy, muscle health, and immune aging.

Evidence comparisons not yet run for these claims.

Expert Consensus

Pending review
1/5
Experts mention
1
Recommend
1
Flag caution
MH
Mark Hyman Recommends Caution
Pending review26 claims1000mg

Evidence Summary

PubMed / NCBI·May 2026
All 20 studies
20
Studies
7
RCTs
13
Reviews

Urolithin A (UA) is a natural compound produced by gut bacteria from polyphenols found in foods like pomegranates, berries, and walnuts. The available research base includes several randomized controlled trials (RCTs) in humans alongside multiple narrative and systematic reviews, suggesting a genuinely emerging — though still maturing — body of evidence. The compound has attracted scientific interest primarily for its ability to promote mitophagy (the cellular process of clearing damaged mitochondria) and support mitochondrial health, with downstream implications for muscle function, aging, immune health, and inflammation.

Read full evidence summary →

Top studies

The anti-obesity effects of postbiotics: A systematic review of pre-clinical and clinical studies.

Clinical nutrition ESPEN · 2024 · Eslami M et al.
Systematic Review🟢
Key finding

The anti-obesity effects of postbiotics: A systematic review of pre-clinical and clinical studies.

COI: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PMID: 39461594DOI: 10.1016/j.clnesp.2024.10.153
View on PubMed

Impact of nutraceuticals and dietary supplements on mitochondria modifications in healthy aging: a systematic review of randomized controlled trials.

Aging clinical and experimental research · 2022 · Lippi L et al.
Systematic Review🟢
Key finding

Impact of nutraceuticals and dietary supplements on mitochondria modifications in healthy aging: a systematic review of randomized controlled trials.

PMID: 35920994DOI: 10.1007/s40520-022-02203-y
View on PubMed

Expert Mentions

All 26 mentions
MH
Mark Hyman
Cleveland Clinic Center for Functional Medicine
Caution / warning

not all urolithin A is clinically tested and third-party certified

Extracted claim

Not all urolithin A products are clinically tested and third-party certified, which is a reason to choose Mitopure specifically.

Not yet assessedHigh confidence
MH
Mark Hyman
Cleveland Clinic Center for Functional Medicine
Caution / warning

not all urolithin A is clinically tested and third-party certified

Extracted claim

Not all urolithin A products are clinically tested and third-party certified, which is a reason to choose Mitopure specifically.

Not yet assessedHigh confidence

Shop Urolithin A

View on Amazon

As an Amazon Associate, Abstraction Health earns from qualifying purchases at no extra cost to you.

Key findings

  • ·Multiple RCTs suggest UA supplementation may improve muscle endurance and mitochondrial health markers in older adults, with one trial specifically focused on this population.
  • ·An RCT in male athletes found potential benefits for muscle endurance, strength, oxidative stress, and inflammation markers over 8 weeks of supplementation.
  • ·Direct UA supplementation appears to produce more consistent blood levels across individuals than dietary intake alone, which is limited by gut microbiome variability — a finding from a dedicated RCT on bioavailability.

Evidence gaps

  • ·Most human RCTs appear to be relatively small and short-term (weeks to a few months), leaving long-term efficacy and safety largely untested in large populations.
  • ·Many of the supporting studies are narrative reviews rather than primary research, meaning much of the mechanistic evidence is synthesized from animal or in vitro studies rather than direct human trials.
  • ·It remains unclear which specific populations benefit most — research spans healthy adults, older adults, and trained athletes, but data in clinical populations (e.g., those with chronic disease, sarcopenia, or age-related macular degeneration) is largely theoretical or review-based at this stage.